基于癌症等级的肝细胞癌的预后模型
Guo-Xin Zhang1, Xiao-Sheng Ding2, You-Li Wang3
1Department of General Surgery, Aviation General Hospital, Beijing 100010, China.
World journal of clinical cases
|October 30, 2023
概括
研究人员确定了13个关键基因,以创建肝细胞癌 (HCC) 预后模型. 这个模型准确地预测了原发性肝癌患者的结果,有助于临床决策.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,预后不佳.
- HCC的分子机制和病因在很大程度上是未知的.
- 确定预后标志物对于改善HCC患者的治疗结果至关重要.
研究的目的:
- 识别与HCC患者预后相关的特征基因.
- 开发一种对肝细胞癌存活率的预测模型.
- 了解HCC中预后基因的生物功能.
主要方法:
- 跨HCC等级的基因表达差异分析.
- 蛋白与蛋白相互作用 (PPI) 网络分析以确定枢纽基因.
- 最小绝对收缩和选择运算符 (LASSO) 考克斯回归用于模型构建.
主要成果:
- 一个包括13个基因的预后模型成功地建立了HCC.
- 开发的模型在HCC患者中显示出显著的预后能力.
- 分析揭示了与这些预后基因相关的生物功能.
结论:
- 为肝细胞癌 (HCC) 构建了一个13基因的预后模型.
- 该模型显示了对HCC的显著预后价值和临床适用性.
- 基因表达特征分析有助于理解HCC进展和患者分层.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.3K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
